Log in to save to my catalogue

Pharmacotherapeutic Management of Metastatic, Castration-Resistant Prostate Cancer in the Elderly: F...

Pharmacotherapeutic Management of Metastatic, Castration-Resistant Prostate Cancer in the Elderly: F...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4418948

Pharmacotherapeutic Management of Metastatic, Castration-Resistant Prostate Cancer in the Elderly: Focus on Non-Chemotherapy Agents

About this item

Full title

Pharmacotherapeutic Management of Metastatic, Castration-Resistant Prostate Cancer in the Elderly: Focus on Non-Chemotherapy Agents

Publisher

Cham: Springer International Publishing

Journal title

Drugs & aging, 2014-12, Vol.31 (12), p.873-882

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

In the past 4 years, five new agents have been approved for metastatic, castration-resistant prostate cancer. Four of them are non-chemotherapeutic and generally well tolerated. However, each has toxicities that can negatively impact patients, particularly the elderly. This review covers the epidemiology of prostate cancer in elderly men. It discus...

Alternative Titles

Full title

Pharmacotherapeutic Management of Metastatic, Castration-Resistant Prostate Cancer in the Elderly: Focus on Non-Chemotherapy Agents

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4418948

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4418948

Other Identifiers

ISSN

1170-229X

E-ISSN

1179-1969

DOI

10.1007/s40266-014-0224-y

How to access this item